Cyclin D1 is a direct transcriptional target of GATA3 in neuroblastoma tumor cells

Oncogene

Volumn 29, Issue 18, 2010, Pages 2739-2745

  Molenaar, J J ^a   Ebus, M E ^a   Koster, J ^a   Santo, E ^a   Geerts, D ^a   Versteeg, R ^a   Caron, H N ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

CCND1; ChIP; GATA3; Microarray; Neuroblastoma

Indexed keywords

CYCLIN D1; TRANSCRIPTION FACTOR GATA 3;

ARTICLE; BINDING SITE; CHROMATIN IMMUNOPRECIPITATION; COMPUTER MODEL; DOWN REGULATION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENE SILENCING; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROMOTER REGION; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION REGULATION; UPREGULATION;

BINDING SITES; CYCLIN D1; GATA3 TRANSCRIPTION FACTOR; GENE EXPRESSION PROFILING; HUMANS; NEUROBLASTOMA; PROMOTER REGIONS, GENETIC; TRANSCRIPTION, GENETIC;

EID: 77952239323     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.21     Document Type: Article

References (23)

1. Albanese C, Johnson J, Watanabe G, Eklund N, Vu D, Arnold A et al. (1995). Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J Biol Chem 270: 23589-23597.
2. Caren H, Erichsen J, Olsson L, Enerback C, Sjoberg RM, Abrahamsson J et al. (2008). High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors: four cases of homozygous deletions of the CDKN2A gene. BMC Genomics 9: 353.
3. Eeckhoute J, Keeton EK, Lupien M, Krum SA, Carroll JS, Brown M. (2007). Positive cross-regulatory loop ties GATA-3 to estrogen receptor alpha expression in breast cancer. Cancer Res 67: 6477-6483.
4. Hanahan D, Weinberg RA. (2000). The hallmarks of cancer. Cell 100: 57-70.
5. Hoch RV, Thompson DA, Baker RJ, Weigel RJ. (1999). GATA-3 is expressed in association with estrogen receptor in breast cancer. Int J Cancer 84: 122-128.
6. Hong SJ, Choi HJ, Hong S, Huh Y, Chae H, Kim KS. (2008). Transcription factor GATA-3 regulates the transcriptional activity of dopamine beta-hydroxylase by interacting with Sp1 and AP4. Neurochem Res 33: 1821-1831.
7. Hong SJ, Huh Y, Chae H, Hong S, Lardaro T, Kim KS. (2006). GATA-3 regulates the transcriptional activity of tyrosine hydroxylase by interacting with CREB. J Neurochem 98: 773-781.
8. Kouros-Mehr H, Kim JW, Bechis SK, Werb Z. (2008). GATA-3 and the regulation of the mammary luminal cell fate. Curr Opin Cell Biol 20: 164-170.
9. Kouros-Mehr H, Slorach EM, Sternlicht MD, Werb Z. (2006). GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland. Cell 127: 1041-1055.
10. Lim KC, Lakshmanan G, Crawford SE, Gu Y, Grosveld F, Engel JD. (2000). Gata3 loss leads to embryonic lethality due to noradrenaline deficiency of the sympathetic nervous system. Nat Genet 25: 209-212.
11. Maris JM, Hogarty MD, Bagatell R, Cohn SL. (2007). Neuroblasto-ma. Lancet 369: 2106-2120.
12. Michels E, Vandesompele J, De Preter K, Hoebeeck J, Vermeulen J, Schramm A et al. (2007). ArrayCGH-based classification of neuroblastoma into genomic subgroups. Genes Chromosomes Cancer 46: 1098-1108.
13. Molenaar JJ, Ebus ME, Koster J, van Sluis P, van Noesel CJ, Versteeg R et al. (2008). Cyclin D1 and CDK4 activity contribute to the undifferentiated phenotype in neuroblastoma. Cancer Res 68: 2599-2609.
14. Molenaar JJ, van Sluis P, Boon K, Versteeg R, Caron HN. (2003). Rearrangements and increased expression of cyclin D1 (CCND1) in neuroblastoma. Genes Chromosomes Cancer 36: 242-249.
15. Pei XH, Bai F, Smith MD, Usary J, Fan C, Pai SY et al. (2009). CDK inhibitor p18(INK4c) is a downstream target of GATA3 and restrains mammary luminal progenitor cell proliferation and tumorigenesis. Cancer Cell 15: 389-401.
16. Sherr CJ. (1996). Cancer cell cycles. Science 274: 1672-1677.
17. Tsarovina K, Pattyn A, Stubbusch J, Muller F, van der WJ, Schneider C et al. (2004). Essential role of Gata transcription factors in sympathetic neuron development. Development 131: 4775-4786.
18. Usary J, Llaca V, Karaca G, Presswala S, Karaca M, He X et al. (2004). Mutation of GATA3 in human breast tumors. Oncogene 23: 7669-7678.
19. Vallania F, Schiavone D, Dewilde S, Pupo E, Garbay S, Calogero R et al. (2009). Genome-wide discovery of functional transcription factor binding sites by comparative genomics: the case of Stat3. Proc Natl Acad Sci USA 106: 5117-5122.
20. van Limpt V, Schramm A, van Lakeman A, Sluis P, Chan A, van Noesel M et al. (2004). The Phox2B homeobox gene is mutated in sporadic neuroblastomas. Oncogene 23: 9280-9288.
21. van Noesel MM, Versteeg R. (2004). Pediatric neuroblastomas: genetic and epigenetic 'danse macabre'. Gene 325: 1-15.
22. van Roy N, Forus A, Myklebost O, Cheng NC, Versteeg R, Speleman F. (1995). Identification of two distinct chromosome 12-derived amplification units in neuroblastoma cell line NGP. Cancer Genet Cytogenet 82: 151-154.
23. Wilson BJ, Giguere V. (2008). Meta-analysis of human cancer microarrays reveals GATA3 is integral to the estrogen receptor alpha pathway. Mol Cancer 7: 49.